Yes, they are spending like crazy, but you have to admit an addition that brings someone with ranking prior FDA and NIH experience adds some value too.
I feel it is a positive step. (This time it was not just a dream or a promise)
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.